The GLP-1 revolution is reshaping obesity care, revealing how primary care economics and reimbursement gaps leave patients ...
There’s no shortage of headlines and hypotheticals about the blockbuster drug class of GLP-1s. Stephen Klasko, MD, argues we’re asking the wrong questions about GLP-1s. For health system leaders, the ...
DexCom (NasdaqGS:DXCM) is seeing higher adoption of its continuous glucose monitoring systems among patients using GLP-1 drugs, as physicians pair both therapies for diabetes care. The company is ...
Soaring in popularity, GLP-1 medications—from weekly injections to newly available pills—are rapidly reshaping how Americans ...
LifeVantage expands its MindBody GLP-1 System™ internationally after notable U.S. revenue growth, targeting holistic wellness and metabolic health. LifeVantage Corporation is expanding its MindBody ...
Appetite is governed by gut hormones, not willpower. GLP-1 therapies extend natural satiety signals and expose the biology behind eating.
SoWell is unveiling GLP-1 Support System, a three-part supplement system designed specifically for GLP-1 users and their side effects. Alexandra Sowa, board-certified obesity medicine specialist, and ...
Data analyses show that people with Type 2 diabetes using GLP-1 medicines saw a significant improvement in their HbA1C after adding FreeStyle Libre technology to their regimen Better HbA1c results ...
Wegovy is available now for cash-paying customers through TrumpRx for $149 a month for the 1.5 mg tablet and $199 for the 4 mg tablet for cash-paying patients. An Ozempic pill will be available in the ...
GLP-1 drugs such as Ozempic and Mounjaro are a revolution, not a trend. These weight loss drugs are one of the hottest markets in healthcare, and there’s been a dramatic surge in the number of ...
This review examines how GLP-1 receptor agonists may influence neurodegenerative disease biology through metabolic, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results